While the positive news about Moderna’s coronavirus vaccine trials is understandably exciting, the story behind their success offers organizations in every sector a dramatic opportunity to take a giant leap forward in their own industries. Among the key players quietly helping Moderna drive efficiencies at a previously unthinkable scale are Harvard Business School Professors and…
